Parc des Bellevues
Allée R. Luxemburg Le Californie
Eragny-sur-Oise 95610
France
33 1 34 21 50 00
https://www.safeorthopaedics.com
Settore/i:
Settore:
Impiegati a tempo pieno: 138
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Pierre Dumouchel | Co-Founder, CEO & Chairman | 220,55k | N/D | 1980 |
Mr. Thomas Droulout | Co-Founder, CTO & Director | N/D | N/D | 1976 |
Mr. Francois-Henri Reynaud | Chief Financial and Administrative Officer & Director | N/D | N/D | 1978 |
Adam Ross | Director of Marketing | N/D | N/D | N/D |
Ms. Nathalie Vazquez | Human Resources Director | N/D | N/D | N/D |
Mr. Nikolaus Beyer | Chief Commercial Officer | N/D | N/D | N/D |
Safe Orthopaedics SA, a medical technology company, engages in the design, manufacturing, and marketing of sterile implants and single-use sterile surgical instruments for the treatment of spinal surgery. The company's products portfolio includes SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies, as well as essential kit for percutaneous treatment of spinal fractures; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. Safe Orthopaedics SA was founded in 2010 and is headquartered in Eragny-sur-Oise, France.
L'ISS Governance QualityScore di Safe Orthopaedics SA al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.